Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Hyperfine A | HYPR | Apr 17, 2025 | 0.70 | +4.11 |
Hyperscale Data | GPUS | Apr 17, 2025 | 2.25 | +1.35 |
Hyster-Yale A | HY | Apr 17, 2025 | 38.26 | +0.68 |
i-80 Gold | IAUX | Apr 17, 2025 | 0.61 | -0.16 |
I-MAB ADR | IMAB | Apr 17, 2025 | 0.85 | +0.46 |
i3 Verticals | IIIV | Apr 17, 2025 | 25.15 | +0.20 |
IAC | IAC | Apr 17, 2025 | 33.02 | +0.82 |
Iamgold | IAG | Apr 17, 2025 | 7.83 | -3.21 |
IB Acquisition | IBAC | Apr 17, 2025 | 10.34 | 0.00 |
IBEX | IBEX | Apr 17, 2025 | 23.35 | -0.47 |
IBio | IBIO | Apr 17, 2025 | 0.89 | -9.18 |
IBM | IBM | Apr 17, 2025 | 238.81 | +0.10 |
Ibotta | IBTA | Apr 17, 2025 | 47.69 | +4.95 |
Iboxx $ High Yield Corporate Bd Ishares | HYG | Apr 17, 2025 | 77.77 | +0.58 |
Iboxx $ Invest Grade Corp Bond Ishares | LQD | Apr 17, 2025 | 106.75 | -0.14 |
Iboxx 3Yr Target Dur Tips ETF Flexshares | TDTT | Apr 17, 2025 | 24.15 | +0.17 |
Iboxx 5Yr Target Dur Tips ETF Flexshares | TDTF | Apr 17, 2025 | 23.84 | +0.25 |
icad | ICAD | Apr 17, 2025 | 3.22 | +4.89 |
Icahn Enterprises | IEP | Apr 17, 2025 | 8.54 | +2.03 |
ICC | ICCH | Apr 17, 2025 | 23.49 | 0.00 |
IceCure Medical | ICCM | Apr 17, 2025 | 1.13 | -1.32 |
ICF International | ICFI | Apr 17, 2025 | 82.98 | +0.23 |
Ichor | ICHR | Apr 17, 2025 | 17.32 | +1.49 |
ICICI Bank ADR | IBN | Apr 17, 2025 | 33.22 | +3.91 |
ICL | ICL | Apr 17, 2025 | 6.37 | +0.95 |
iClick Interactive Asia ADR | ICLK | Apr 17, 2025 | 9.24 | 0.00 |
ICON | ICLR | Apr 17, 2025 | 139.32 | -2.94 |
Icon Energy | ICON | Apr 17, 2025 | 2.14 | +0.47 |
iCoreConnect | ICCT | Apr 17, 2025 | 2.43 | -14.44 |
ICU Medical | ICUI | Apr 17, 2025 | 138.67 | -0.34 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.